MedTrace Logo

Irritable Bowel Syndrome and Lactibiane Tolerance

NCT01529359 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 123

Last updated 2021-04-20

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effects of a probiotic combination (Lactibiane Tolerance) on the severity of symptoms in patients with irritable bowel syndrome (IBS).

Conditions

  • Irritable Bowel Syndrome

Interventions

DIETARY_SUPPLEMENT

Lactibiane Tolerance

Probiotics combination 2 gelules per days during 6 weeks

DIETARY_SUPPLEMENT

Placebo

Placebo 2 gelules per days for 6 weeks

Sponsors & Collaborators

  • PiLeJe

    lead INDUSTRY

Principal Investigators

  • Piche Thierry, MD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-24
Primary Completion
2013-02-04
Completion
2013-02-11

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01529359 on ClinicalTrials.gov